Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?
- PMID: 37010071
- DOI: 10.1080/14779072.2023.2199155
Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?
Keywords: P2Y12 receptor antagonists; antiplatelet agents; aspirin; cardiovascular disease; secondary prevention.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources